Related Experiment Video
Updated: May 10, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Does early life exposure to antibiotics increase the risk of eczema? A systematic review
T Tsakok1, T M McKeever, L Yeo
1Academic Clinical Fellow/Core Medical Trainee, Guy's and St Thomas' Hospital NHS Foundation Trust, Westminster Bridge Road, London, SE1 7EH, U.K.
Insights
Early antibiotic exposure in the first year of life increases eczema risk in children. This systematic review found a 41% higher risk for postnatal antibiotic exposure, with a dose-response relationship observed.
Area of Science:
- Pediatrics
- Dermatology
- Pharmacology
Background:
- Early life antibiotic exposure is a growing concern.
- Studies suggest a link between antibiotics and eczema development.
Purpose of the Study:
- To systematically review and meta-analyze observational studies.
- To assess the impact of early life antibiotic exposure on eczema risk.
Main Methods:
- Systematic review and meta-analysis of 20 observational studies.
- Inclusion of children and young adults aged 0-25 years.
- Analysis of prenatal and/or first-year postnatal antibiotic exposure.
Main Results:
- Postnatal antibiotic exposure showed a pooled odds ratio (OR) of 1.41 (95% CI 1.30-1.53).
- A significant dose-response was found: a 7% increased eczema risk per additional antibiotic course in the first year.
- Antenatal exposure did not show a significant association (OR 1.30, 95% CI 0.86-1.95).
Conclusions:
- Antibiotic exposure during the first year of life is associated with an increased risk of eczema.
- Prenatal antibiotic exposure was not significantly linked to eczema development in this review.
- Findings highlight the importance of judicious antibiotic use in early childhood.
Abstract:
A number of studies have suggested that early life exposure to antibiotics can lead to an increased risk of developing eczema. This systematic review and meta-analysis of observational studies, involving children or young adults aged 0-25 years, assessed the impact of antibiotic exposure either in utero or during the first 12 months of life on subsequent eczema risk. Twenty studies examined the association between prenatal and/or postnatal exposure to antibiotics and development of eczema. The pooled odds ratio (OR) for the 17 studies examining postnatal antibiotic exposure was 1.41 [95% confidence interval (CI) 1.30-1.53]. The pooled OR for the 10 longitudinal studies was 1.40 (95% CI 1.19-1.64), compared with a pooled OR of 1.43 (95% CI 1.36-1.51) for the seven cross-sectional studies. There was a significant dose-response association, suggesting a 7% increase in the risk of eczema for each additional antibiotic course received during the first year of life [pooled OR 1.07 (95% CI 1.02-1.11)]. Finally, the pooled OR for the four studies relating to antenatal exposure was 1.30 (95% CI 0.86-1.95). We conclude that exposure to antibiotics in the first year of life, but not prenatally, is more common in children with eczema.
Related Concept Videos
Acne Infection
Asthma I: Introduction
Development of Human Microbiota
Development of the Oral Microbiota
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Clinical Significance of Antibiotic Resistance

